Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Dyadic International's Enterprise Value is $53.01 Mil.
Dyadic International's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $-5.72 Mil. Therefore, Dyadic International's EV-to-OCF for today is -9.28.
The historical rank and industry rank for Dyadic International's EV-to-OCF or its related term are showing as below:
DYAI'
s EV-to-OCF Range Over the Past 10 Years
Min: -37.59 Med: -6.02 Max: 4.31
Current: -9.28
During the past 13 years, the highest EV-to-OCF of Dyadic International was 4.31. The lowest was -37.59. And the median was -6.02.
DYAI's EV-to-OCF is ranked better than 65.77% of 1411
companies
in the Biotechnology industry
Industry Median: -3.26
vs DYAI: -9.28
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Dyadic International (NAS:DYAI) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Dyadic International's PE Ratio (TTM) for today is calculated as:
Dyadic International's share price for today is $1.47.
Dyadic International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.230.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Dyadic International EV-to-OCF Related Terms
Dyadic International EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Dyadic International's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Dyadic International's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dyadic International EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Dyadic International's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Dyadic International's EV-to-OCF falls into.
Dyadic International's current Enterprise Value is $53.01 Mil.
Dyadic International's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.72 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dyadic International (DYAI) has a EV-to-OCF of -9.28 as of Jul. 21, 2026. According to the industry distribution chart, Dyadic International ranks #483 out of 1411 companies in the Biotechnology industry, placing it in the top 34.2%.
Is Dyadic International's EV-to-OCF too high?
Dyadic International's current EV-to-OCF is -9.28. Based on the distribution chart, Dyadic International ranks #483 out of 1411 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Dyadic International has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dyadic International's EV-to-OCF compare to GRDX and TVGN?
According to the Biotechnology industry distribution chart, Dyadic International ranks #483 out of 1411 companies for EV-to-OCF. This puts Dyadic International in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Dyadic International's current EV-to-OCF is -9.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dyadic International stock overvalued right now?
Based on GuruFocus' analysis, Dyadic International (DYAI) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.74, compared to a current price of $1.47 — trading 98.6% above its estimated fair value. The current EV-to-OCF is -9.28. Dyadic International's overall GF Score™ is 37/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Dyadic International (DYAI), the current EV-to-OCF is -9.28 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dyadic International (DYAI) Overvalued in 2026?
Based on GuruFocus' analysis, Dyadic International stock appears to be overvalued.
The current stock price of $1.47 is trading 98.6% above its estimated GF Value™ of $0.74.
GuruFocus considers Dyadic International to be Significantly Overvalued.
Key valuation signals for DYAI:
EV-to-OCF: -9.28
GF Value™: $0.74 vs. price of $1.47 (98.6% above fair value)
No single metric tells the full story. See the DYAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
37GF Score
Get the complete analysis for DYAI
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DYAI has been successfully added to your 
